WeLeader Biomedical Co., Ltd.

TPEX:7713 Stock Report

Market Cap: NT$3.3b

WeLeader Biomedical Valuation

Is 7713 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7713 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 7713's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 7713's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7713?

Key metric: As 7713 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for 7713. This is calculated by dividing 7713's market cap by their current book value.
What is 7713's PB Ratio?
PB Ration/a
BookNT$0
Market CapNT$3.35b

Price to Book Ratio vs Peers

How does 7713's PB Ratio compare to its peers?

The above table shows the PB ratio for 7713 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average1.2x
4745 Cowealth Medical Holding
0.6xn/aNT$1.6b
4173 Arich Enterprise
0.8xn/aNT$1.6b
1788 Hi-Clearance
2.1xn/aNT$6.2b
6496 Excelsior Biopharma
1.4xn/aNT$1.4b
7713 WeLeader Biomedical
n/an/aNT$3.3b

Price-To-Book vs Peers: Insufficient data to calculate 7713's Price-To-Book Ratio vs. peers for valuation analysis.


Price to Book Ratio vs Industry

How does 7713's PB Ratio compare vs other companies in the TW Healthcare Industry?

0 CompaniesPrice / BookEstimated GrowthMarket Cap
7713 is unprofitableIndustry Avg. 1.6xNo. of Companies5PB01.22.43.64.86+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: Insufficient data to calculate 7713's Price-To-Book Ratio vs. industry for valuation analysis.


Price to Book Ratio vs Fair Ratio

What is 7713's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7713 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ration/a
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate 7713's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies